Onward Medical N.V. (FRA:63E)

Market Cap	185.00M -32.3%
Revenue (ttm)	2.72M +226.9%
Net Income	-38.65M
EPS	-0.78
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5
Average Volume	38
Open	4.110
Previous Close	4.115
Day's Range	4.065 - 4.110
52-Week Range	3.490 - 5.780
Beta	n/a
RSI	42.63
Earnings Date	Mar 27, 2026

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Ki...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2014
• Employees: 103
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 63E

Financial Performance

In 2024, Onward Medical's revenue was 1.74 million, an increase of 226.88% compared to the previous year's 532,000. Losses were -35.73 million, -1.26% less than in 2023.